BACKGROUND/AIM: Total-body irradiation (TBI) doses in the range of 2-8 Gy are associated with a drop in peripheral blood counts, decreased bone marrow cellularity, and hematopoietic syndrome. Radiation mitigators must be safe for individuals likely to recover spontaneously. MATERIALS AND METHODS: Female C57BL/6HNsd mice exposed to 9.0 and 9.15 Gy TBI, received intraperitoneal (10 mg/kg) JP4-039, a novel radiation mitigator, 24 hours after irradiation and were followed for hematopoietic recovery. RESULTS: Irradiated mice showed reduced peripheral blood lymphocytes and neutrophils and bone marrow cellularity at day 5. Serum electrolytes, liver and renal function tests showed no deleterious effect of JP4-039-after irradiation, and no reduction in survival compared to irradiated controls. Marrow recovery measured as cellularity, and hematopoietic colony-forming cells including primitive granulocyte-erythroid-megakaryocyte-monocytes (GEMM), reached pre-irradiation levels by day 30 in JP4-039 treated groups. Mice receiving single or multiple administrations of JP4-039 showed an early return of CFU-GEMM. CONCLUSION: JP4-039 (GS-Nitroxide) is a safe radiation mitigator in mice warranting studies in larger animals and potentially a Phase I Clinical Trial.
BACKGROUND/AIM: Total-body irradiation (TBI) doses in the range of 2-8 Gy are associated with a drop in peripheral blood counts, decreased bone marrow cellularity, and hematopoietic syndrome. Radiation mitigators must be safe for individuals likely to recover spontaneously. MATERIALS AND METHODS: Female C57BL/6HNsd mice exposed to 9.0 and 9.15 Gy TBI, received intraperitoneal (10 mg/kg) JP4-039, a novel radiation mitigator, 24 hours after irradiation and were followed for hematopoietic recovery. RESULTS: Irradiated mice showed reduced peripheral blood lymphocytes and neutrophils and bone marrow cellularity at day 5. Serum electrolytes, liver and renal function tests showed no deleterious effect of JP4-039-after irradiation, and no reduction in survival compared to irradiated controls. Marrow recovery measured as cellularity, and hematopoietic colony-forming cells including primitive granulocyte-erythroid-megakaryocyte-monocytes (GEMM), reached pre-irradiation levels by day 30 in JP4-039 treated groups. Mice receiving single or multiple administrations of JP4-039 showed an early return of CFU-GEMM. CONCLUSION:JP4-039 (GS-Nitroxide) is a safe radiation mitigator in mice warranting studies in larger animals and potentially a Phase I Clinical Trial.
Authors: D S Krause; N D Theise; M I Collector; O Henegariu; S Hwang; R Gardner; S Neutzel; S J Sharkis Journal: Cell Date: 2001-05-04 Impact factor: 41.582
Authors: Michael W Epperly; Darcy Franicola; Donna Shields; Jean-Claude Rwigema; Brandon Stone; Xichen Zhang; William McBride; George Georges; Peter Wipf; Joel S Greenberger Journal: In Vivo Date: 2010 Jan-Feb Impact factor: 2.155
Authors: Ronny Kalash; Michael W Epperly; Julie Goff; Tracy Dixon; Melissa M Sprachman; Xichen Zhang; Donna Shields; Shaonan Cao; Darcy Franicola; Peter Wipf; Hebist Berhane; Hong Wang; Jeremiah Au; Joel S Greenberger Journal: Radiat Res Date: 2013-10-14 Impact factor: 2.841
Authors: Michael W Epperly; Peter Wipf; Renee Fisher; Darcy Franicola; Jan Beumer; Song Li; Rhonda M Brand; Louis D Falo; Geza Erdos; Joel S Greenberger Journal: In Vivo Date: 2018 Sep-Oct Impact factor: 2.155
Authors: Michael W Epperly; Joshua R Sacher; Tanja Krainz; Xiaolin Zhang; Peter Wipf; Mary Liang; Renee Fisher; Song Li; Hong Wang; Joel S Greenberger Journal: In Vivo Date: 2017-01-02 Impact factor: 2.155
Authors: Stephanie Thermozier; Xichen Zhang; Wen Hou; Renee Fisher; Michael W Epperly; Bing Liu; Ivet Bahar; Hong Wang; Joel S Greenberger Journal: Radiat Res Date: 2019-07-11 Impact factor: 2.841
Authors: Justin Steinman; Michael Epperly; Wen Hou; John Willis; Hong Wang; Renee Fisher; Bing Liu; Ivet Bahar; Travis McCaw; Valerian Kagan; Hulya Bayir; Jian Yu; Peter Wipf; Song Li; M Saiful Huq; Joel S Greenberger Journal: Radiat Res Date: 2017-11-15 Impact factor: 2.841
Authors: Rhonda M Brand; Michael W Epperly; J Mark Stottlemyer; Erin M Skoda; Xiang Gao; Song Li; Saiful Huq; Peter Wipf; Valerian E Kagan; Joel S Greenberger; Louis D Falo Journal: J Invest Dermatol Date: 2016-10-26 Impact factor: 8.551
Authors: Xiang Gao; Yixian Huang; Alexander M Makhov; Michael Epperly; Jianqin Lu; Sheila Grab; Peijun Zhang; Lisa Rohan; Xiang-Qun Xie; Peter Wipf; Joel Greenberger; Song Li Journal: Mol Pharm Date: 2012-12-17 Impact factor: 4.939
Authors: Marie-Céline Frantz; Erin M Skoda; Joshua R Sacher; Michael W Epperly; Julie P Goff; Joel S Greenberger; Peter Wipf Journal: Org Biomol Chem Date: 2013-07-07 Impact factor: 3.876